Table-I.
Comparison of ACHRAB, absolute clinical score and levels of C3 and C4 between the two groups (x±s).
| Group | Time | No. of cases | AChRab (nmol/L) | Clinical absolute score (points) | C3 (g/L) | C4 (g/L) |
|---|---|---|---|---|---|---|
| Experimental group | Before treatment | 49 | 0.89±0.07 | 25.89±3.64 | 0.99±0.12 | 0.18±0.03 |
| 1 month after treatment | 49 | 0.61±0.06* | 18.20±2.36* | 1.15±0.17* | 0.22±0.03* | |
| 3 months after treatment | 49 | 0.41±0.05*# | 11.56±2.41*# | 1.42±0.18*# | 0.29±0.04*# | |
| Control group | Before treatment | 49 | 0.88±0.08 | 26.03±3.78 | 1.01±0.10 | 0.19±0.03 |
| 1 month after treatment | 49 | 0.56±0.07* | 17.56±2.15* | 1.18±0.16* | 0.23±0.03* | |
| 3 months after treatment | 49 | 0.48±0.07* | 13.86±2.05* | 1.32±0.15* | 0.25±0.03* |
Note:
*
p<0.05 compared with that before treatment in this group;
#
p<0.05 compared with that in the control group at the same time.